Topic: Alzheimer’s

Latest

NICE rules newly-approved Alzheimer’s-slowing drug too costly for NHS

NICE rules newly-approved Alzheimer’s-slowing drug too costly for NHS

NICE rules Alzheimer’s-slowing drug lecanemab too expensive for NHS

NICE rules Alzheimer’s-slowing drug lecanemab too expensive for NHS

22nd August 2024

Drugs used to treat erectile dysfunction may reduce Alzheimer’s disease risk

Drugs used to treat erectile dysfunction may reduce Alzheimer’s disease risk

14th February 2024

Donanemab ‘effective’ But ‘a Way Off’, Says Expert

Alzheimer’s drug donanemab ‘effective’ but ‘a way off’, says expert

19th July 2023

Alzheimer’s: ‘Drastic changes’ in testing access needed to make most of ‘historic’ new drug

Alzheimer’s: ‘Drastic changes’ in testing access needed to make most of ‘historic’ new drug

30th November 2022